United States Bispecific Antibodies Market Size & Outlook, 2025-2031
United States Bispecific Antibodies Market Size
According to Straits Research analysis, The United States Bispecific Antibodies Market was valued at USD 2057.53 Million in 2024 and is projected to reach USD 5022.22 Million by 2031, expanding at a CAGR of 14.4% during the forecast period. This rapid growth is mainly driven by its use in the health sector, with key applications in oncology, auto-immune diseases, and infectious diseases. The pharmaceutical and biotechnological industries are primary contributors to the increasing demand. Key market drivers include ongoing research and development initiatives, technological advancements in antibody therapies, and a rise in export opportunities. The increasing focus on low-carbon production methods may herald an age of sustainable bispecific antibodies. Looking ahead, the United States is strategically positioning itself as a leader in the bispecific antibodies market by continuously investing in technology and prioritizing sustainable practices.
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Bispecific Antibodies Market Highlights
- Bi-specific T-cell engager held the leading position among Type segments in 2024, based on market size.
- Bi-specific T-cell engager is projected to post the fastest growth rate, sustaining its position as the most attractive Type segment during the forecast horizon.
- United States accounted for 37.33% of the global bispecific antibodies market size in 2024.
- By 2031, United States is expected to remain the top global market in terms of size.
- Within North America, United States is forecasted to dominate the regional bispecific antibodies market size by 2031.
- Canada will be the fastest-growing market in North America, projected to achieve USD 132.59 Million by 2031.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2031 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2031 |
| Market Size In 2024 | USD 2057.53 Million |
| Market Size In 2031 | USD 5022.22 Million |
| Largest segment | Bi-specific T-cell engager |
| Fastest segment | Bi-specific T-cell engager |
| Units | Revenue in USD Million |
| CAGR | 14.4% (2025-2031) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United States Bispecific Antibodies Market Share By Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Type |
|
| Therapeutic Areas |
|
| Target |
|
United States Bispecific Antibodies Market By Type 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Bispecific Antibodies Market By Therapeutic Areas 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
United States Bispecific Antibodies Market By Target 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
